NCT00619827View on ClinicalTrials.gov

Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract

PHASE1CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

300 IR grass pollen allergen extract tablet

300 IR grass pollen allergen extract tablet once daily during four months

DRUG

Placebo tablet

Placebo tablet once daily during four months

Trial Locations (1)

1150

Allergy Center Vienna West, Vienna Challenge Chamber -, Vienna

Sponsors

Lead Sponsor

Stallergenes Greer
All Listed Sponsors
lead

Stallergenes Greer

INDUSTRY